Preclinical efficacy for a novel tyrosine kinase inhibitor, ArQule 531 against acute myeloid leukemia

Overview of attention for article published in Journal of Hematology & Oncology, January 2020

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 31 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 X post from an account with 925 followers.

New article: Preclinical efficacy for a novel tyrosine kinase inhibitor, ArQule 531 against acute myeloid leukemia. https://t.co/0JbaLG3oix #AML #leusm #hematology

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.